D-0471-2023 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0471-2023 was initiated by Noven Pharmaceuticals Inc on Mar 10, 2023 and is designated Class II. Reason for recall: Defective Delivery System: Out of specification for shear. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2023
Initiation Date
Mar 10, 2023
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

Reason for recall

Defective Delivery System: Out of specification for shear.

Distribution pattern

US Nationwide

Code information

Lot#: 91956, Exp. 6/2023; 92475, Exp. 7/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0471-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0471-2023. Report a data issue: hello@regdatalab.com.